OPRX
OptimizeRx Corporation · NASDAQ
- Sector Technology Services
- Industry Packaged Software
- Website optimizerx.com
- Employees(FY) 109
- ISIN US68401U2042
Performance
-0.41%
1W
+20.34%
1M
-37.53%
3M
-54.62%
6M
-65.69%
YTD
-65.0%
1Y
Profile
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
Technical Analysis of OPRX 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-17 18:30
OptimizeRx to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-11-13 13:15
- 2024-11-13 04:35
OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates(Yahoo Finance)
- 2024-11-13 03:05
OptimizeRx Reports Third Quarter 2024 Financial Results(Globenewswire)
- 2024-11-06 20:12
- 2024-10-30 19:30
- 2024-10-02 16:25
- 2024-09-09 19:30
- 2024-09-09 00:00
- 2024-09-03 21:35
- 2024-08-08 06:25
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates(Yahoo Finance)
- 2024-08-08 04:05
OptimizeRx Reports Second Quarter 2024 Financial Results(Yahoo Finance)
- 2024-07-31 22:01
- 2024-07-24 19:30
- 2024-07-22 19:30
- 2024-07-14 19:30
- 2024-06-19 19:30
- 2024-05-14 08:56
- 2024-05-14 04:01
OptimizeRx Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-05-12 21:55
- 2024-05-06 04:30
OptimizeRx to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-04-25 19:30
- 2024-04-22 21:35
- 2024-04-21 21:35
- 2024-04-17 19:30
- 2024-04-15 19:00
- 2024-04-10 19:30
- 2024-04-05 18:00
7 Top Undervalued Stocks Primed for a Multibagger Recovery(Yahoo Finance)
- 2024-04-01 03:02
- 2024-03-28 09:54
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023(Investorplace)
Page 1 of 5
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.